Ballard S A, Lodola A, Tarbit M H
Biological Laboratory, The University, Canterbury, Kent, U.K.
Biochem Pharmacol. 1988 Dec 15;37(24):4643-51. doi: 10.1016/0006-2952(88)90333-4.
Three imidazole antifungal agents, ketoconazole, miconazole and tioconazole, and a group of structurally related 1-substituted imidazole and 1,2,4-triazole compounds were evaluated as inhibitors of the oxidative metabolism of testosterone catalysed by mouse hepatic microsomal cytochromes P-450. Spectroscopic studies showed that both imidazoles and triazoles interacted with ferric cytochrome P-450 in hepatic microsomes to produce type II difference spectra which could be distinguished by their different absorbance maxima; 429-430 nm and 425-426 nm respectively. Compound 4, which possesses both types of functional group, produced a spectrum which resembled that of imidazole compounds, indicating that the imidazole moiety had a higher affinity than the triazole for the haem of cytochromes P-450 present in microsomes. The test compounds differentially inhibited regio- and stereo-specific testosterone metabolism and the pattern of inhibition varied with the 1-substituent on the azole ring. Ketoconazole was a potent inhibitor of testosterone 6 beta-hydroxylation (IC50 0.08 microM) but was considerably less active against other hydroxylations and 17 beta-oxidation to androstenedione (IC50 range 13 to greater than 100 microM). In contrast, tioconazole (IC50 range 0.18 to 3.3 microM) and miconazole (IC50 range 0.15 to 10 microM) were relatively non-selective. Compounds 1 and 2, which differed from each other only in the type of azole ring, were most active against 16 beta-hydroxylation. The triazole analogue (compound 2) was a significantly more potent inhibitor of 16 beta-hydroxylation than the imidazole (compound 1), equipotent against androstenedione formation and less active against the other hydroxylations. Two relatively polar bis-azole analogues (compounds 3 and 4) were most active against androstenedione formation; however, in general they were less inhibitory than the lipophilic azoles. We conclude that azole antifungal agents of differing structure show different patterns of selective interaction with cytochromes P-450, a phenomenon primarily dependent on the 1-substituent on the azole ring, but also modulated to a lesser extent by the type of azole ring (imidazole or triazole).
对三种咪唑类抗真菌药酮康唑、咪康唑和噻康唑,以及一组结构相关的1-取代咪唑和1,2,4-三唑化合物,进行了作为小鼠肝脏微粒体细胞色素P - 450催化的睾酮氧化代谢抑制剂的评估。光谱研究表明,咪唑类和三唑类化合物均与肝脏微粒体中的铁细胞色素P - 450相互作用,产生II型差示光谱,其可通过不同的最大吸光度加以区分;分别为429 - 430nm和425 - 426nm。同时具有两种官能团类型的化合物4产生的光谱类似于咪唑类化合物的光谱,表明咪唑部分对微粒体中细胞色素P - 450的血红素的亲和力高于三唑部分。受试化合物对睾酮的区域和立体特异性代谢具有不同程度的抑制作用,且抑制模式随唑环上的1-取代基而变化。酮康唑是睾酮6β-羟基化的强效抑制剂(IC50为0.08μM),但对其他羟基化反应以及睾酮向雄烯二酮的17β-氧化反应的活性则低得多(IC50范围为13至大于100μM)。相比之下,噻康唑(IC50范围为0.18至3.3μM)和咪康唑(IC50范围为0.15至10μM)的选择性相对较低。仅在唑环类型上存在差异的化合物1和化合物2对16β-羟基化反应的活性最高。三唑类似物(化合物2)对16β-羟基化反应的抑制作用明显强于咪唑类似物(化合物1),对雄烯二酮形成的抑制作用相当,而对其他羟基化反应的活性较低。两种相对极性的双唑类似物(化合物3和化合物4)对雄烯二酮形成的活性最高;然而,总体而言,它们的抑制作用低于亲脂性唑类化合物。我们得出结论,不同结构的唑类抗真菌药与细胞色素P - 450表现出不同模式的选择性相互作用,这一现象主要取决于唑环上的1-取代基,但也在较小程度上受唑环类型(咪唑或三唑)的调节。